Literature DB >> 34055207

Novel Substituted Exomethylene-oxindoles as HPK1 Inhibitors.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34055207      PMCID： PMC8155272          DOI： 10.1021/acsmedchemlett.1c00172

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  6 in total

Review 1.  Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors.

Authors:  Jiamin Zheng; Jun Wu; Xiao Ding; Hong C Shen; Ge Zou
Journal:  Bioorg Med Chem Lett       Date:  2021-02-18       Impact factor: 2.823

Review 2.  MicroRNAs as regulators of ERK/MAPK pathway: A comprehensive review.

Authors:  Amin Safa; Atefe Abak; Hamed Shoorei; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Biomed Pharmacother       Date:  2020-10-14       Impact factor: 6.529

Review 3.  The functions and regulation of Smurfs in cancers.

Authors:  Lin Fu; Chun-Ping Cui; Xueli Zhang; Lingqiang Zhang
Journal:  Semin Cancer Biol       Date:  2019-12-30       Impact factor: 15.707

Review 4.  MAP4K3/GLK in autoimmune disease, cancer and aging.

Authors:  Huai-Chia Chuang; Tse-Hua Tan
Journal:  J Biomed Sci       Date:  2019-10-22       Impact factor: 8.410

Review 5.  A perspective on HPK1 as a novel immuno-oncology drug target.

Authors:  Sansana Sawasdikosol; Steven Burakoff
Journal:  Elife       Date:  2020-09-08       Impact factor: 8.140
  6 in total
  1 in total

1.  Discovery of Novel HPK1 Inhibitors Through Structure-Based Virtual Screening.

Authors:  Huizhen Ge; Lizeng Peng; Zhou Sun; Huanxiang Liu; Yulin Shen; Xiaojun Yao
Journal:  Front Pharmacol       Date:  2022-03-14       Impact factor: 5.810
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.